09/08/2025
π New Research on PCOS & Semaglutide
Lifestyle changes alone arenβt always enough for women with PCOS struggling with obesity.
In a recent study:
β
27 women with PCOS who didnβt respond to lifestyle changes were treated with Semaglutide (0.5 mg weekly).
β
After just 3 months:
Average BMI reduction of 3.1
Nearly 80% achieved at least 5% body weight loss
β
Reported side effects were minimal.
β¨ Semaglutide is showing real promise as a safe and effective option for women with PCOS when lifestyle changes arenβt enough.
π Want to learn more? Message us today!
In spite of the widespread use of lifestyle modifications programs, many patients with PCOS are obese and prevalence of obesity in PCOS remains high. In this study, we present the data on the use of semaglutide, an incretin mimetic drug, in obese PCOS patients who were unresponsive to a lifestyle mo...